CNBC's Jim Cramer on Wednesday discussed the tricky nature of bad quarters, saying management needs to explain and not gloss over any misses or poor results.
Cramer said every earnings shortfall is "nuanced beyond belief," with some more difficult for Wall Street to parse than others.
The company, which had been seeing success with its popular weight loss and diabetes drugs, failed to properly explain its shortfall, Cramer said.
And while management from Wingstop highlighted the bright spots of the quarter, they largely did not acknowledge the earnings miss, he continued.
AMD, Eli Lilly and Wingstop did not immediately respond to request for comment.
Persons:
CNBC's Jim Cramer, Cramer, Eli Lilly, Wingstop, Wednesday's, Eli Lilly's
Organizations:
Investors, AMD, Nvidia, Wingstop